Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 2,394: Line 2,394:
|}<br />
|}<br />


==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
==WHO Central Nervous System Tumours  (5th ed.) Content==
{| class="wikitable sortable"
{| class="wikitable"
!'''Gene'''
|-
!'''Author'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
|-
|- |Astrocytoma, IDH-mutant||Disease||
|BCR
|
|Brian Davis
|
|
|
|
|
|Complete
|8/10/18
|
|
|
|
|
|
|-
|-
|ABL1
|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
|Brian Davis
|
|
|
|
|
|
|Complete
|4/16/19
|
|
|
|
|
|
|-
|-
|RUNX1
|Glioblastoma, IDH-wildtype||Disease||
|Brian Davis
|
|
|
|
|
|
|Complete
|6/9/19
|
|
|
|
|
|
|-
|-
|RUNX1T1
|Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
|Brian Davis
|
|
|
|
|
|
|Complete
|5/23/19
|
|
|
|
|
|
|-
|-
|MYH11
|Angiocentric glioma||Disease||
|Brian Davis
|
|
|
|
|
|
|Complete
|8/6/18
|
|
|
|
|
|
|-
|-
|FLT3
|Polymorphous low-grade neuroepithelial tumour of the young||Disease||
|Kay Weng Choy
|
|
|
|
|
|Complete
|
|
|
|
Line 2,466: Line 2,458:
|
|
|-
|-
|NPM1
|Diffuse low-grade glioma, MAPK pathway-altered||Disease||
|Kay Weng Choy
|
|
|
|
|
|Complete
|
|
|
|
Line 2,476: Line 2,467:
|
|
|-
|-
|TP53
|Diffuse midline glioma, H3 K27-altered||Disease||
|Kay Weng Choy
|
|
|
|
|
|Complete
|
|
|
|
Line 2,486: Line 2,476:
|
|
|-
|-
|DNMT3A
|Diffuse hemispheric glioma, H3 G34-mutant||Disease||
|Kay Weng Choy
|
|
|
|
|
|Complete
|
|
|
|
Line 2,496: Line 2,485:
|
|
|-
|-
|CEBPA
|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
|Gordana
|
|
|
|
|
|Complete
|
|
|
|
Line 2,506: Line 2,494:
|
|
|-
|-
|IDH1
|Infant-type hemispheric glioma||Disease||
|Paul De Fazio
|
|
|
|
|
|Complete
|
|
|
|
Line 2,516: Line 2,503:
|
|
|-
|-
|IDH2
|Pilocytic astrocytoma||Disease||
|Paul De Fazio
|
|
|
|
|
|Complete
|
|
|
|
Line 2,526: Line 2,512:
|
|
|-
|-
|PML
|High-grade astrocytoma with piloid features||Disease||
|Brian Davis
|
|
|
|
|
|
|Complete
|12/5/18
|
|
|
|
|
|
|-
|-
|RARA
|Pleomorphic xanthoastrocytoma||Disease||
|Brian Davis
|
|
|
|
|
|
|Complete
|8/3/18
|
|
|
|
|
|
|-
|-
|ETV6
|Subependymal giant cell astrocytoma||Disease||
|Brian Davis
|
|
|
|
|Complete
|6/9/19
|
|
|
|
|
|
|-
|KIT
|Brian Davis
|
|
|
|
|Complete
|-
|10/1/18
|Chordoid glioma||Disease||
|
|
|
|
|
|-
|CBFB
|Brian Davis
|
|
|
|
|Complete
|8/2/18
|
|
|
|
|
|
|-
|-
|GATA2
|Astroblastoma, MN1-altered||Disease||
|Kay Weng Choy
|
|
|
|
|
|Complete
|
|
|
|
Line 2,586: Line 2,557:
|
|
|-
|-
|PTEN
|Ganglioglioma||Disease||
|Beth Pitel
|
|
|
|
|
|Pending
|
|
|
|
Line 2,596: Line 2,566:
|
|
|-
|-
|MLTT3
|Gangliocytoma||Disease||
|
|
|
|
Line 2,604: Line 2,574:
|
|
|
|
|-
|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
|
|
|-
|MECOM
|Brian Davis
|
|
|
|
|Pending
|
|
|
|
Line 2,616: Line 2,584:
|
|
|-
|-
|FGFR1(FLT2)
|Dysembryoplastic neuroepithelial tumour||Disease||
|Brian Davis
|
|
|
|
|
|Pending
|
|
|
|
Line 2,626: Line 2,593:
|
|
|-
|-
|KMT2A
|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
|
|
|
|
Line 2,634: Line 2,601:
|
|
|
|
|-
|Papillary glioneuronal tumour||Disease||
|
|
|-
|DEK
|Wahab A. Khan
|
|
|
|
|Pending
|
|
|
|
Line 2,646: Line 2,611:
|
|
|-
|-
|NUP214
|Rosette-forming glioneuronal tumour||Disease||
|Wahab A. Khan
|
|
|
|
|
|Pending
|
|
|
|
Line 2,656: Line 2,620:
|
|
|-
|-
|RBM15
|Myxoid glioneuronal tumour||Disease||
|
|
|
|
Line 2,664: Line 2,628:
|
|
|
|
|-
|Diffuse leptomeningeal glioneuronal tumour||Disease||
|
|
|-
|MKL1
|
|
|
|
Line 2,673: Line 2,637:
|
|
|
|
|-
|Multinodular and vacuolating neuronal tumour||Disease||
|
|
|
|
|-
|DDX41
|Ying Zou
|8/7/20
|
|
|Pending
|
|
|
|
Line 2,686: Line 2,647:
|
|
|-
|-
|ANKRD26
|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
|
|
|
|
|
Line 2,696: Line 2,656:
|
|
|-
|-
|CUX1
|Central neurocytoma||Disease||
|
|
|
|
|
Line 2,706: Line 2,665:
|
|
|-
|-
|TET2
|Extraventricular neurocytoma||Disease||
|
|
|
|
|
Line 2,716: Line 2,674:
|
|
|-
|-
|EZH2
|Cerebellar liponeurocytoma||Disease||
|
|
|
|
|
Line 2,726: Line 2,683:
|
|
|-
|-
|FOXP1
|Supratentorial ependymoma||Disease||
|
|
|
|
|
Line 2,736: Line 2,692:
|
|
|-
|-
|MYC
|Supratentorial ependymoma, ZFTA fusion-positive||Disease||
|
|
|
|
|
Line 2,746: Line 2,701:
|
|
|-
|-
|JAK2
|Supratentorial ependymoma, YAP1 fusion-positive||Disease||
|
|
|
|
Line 2,754: Line 2,709:
|
|
|
|
|-
|Posterior fossa ependymoma||Disease||
|
|
|-
|WT1
|DONE
|
|
|
|
|DONE
|
|
|
|
Line 2,766: Line 2,719:
|
|
|-
|-
|CBL
|Posterior fossa group A (PFA) ependymoma||Disease||
|
|
|
|
|
Line 2,776: Line 2,728:
|
|
|-
|-
|NF1
|Posterior fossa group B (PFB) ependymoma||Disease||
|
|
|
|
|
Line 2,786: Line 2,737:
|
|
|-
|-
|SUZ12
|Spinal ependymoma||Disease||
|
|
|
|
|
Line 2,796: Line 2,746:
|
|
|-
|-
|ERG
|Spinal ependymoma, MYCN-amplified||Disease||
|
|
|
|
|
Line 2,806: Line 2,755:
|
|
|-
|-
|EST2
|Myxopapillary ependymoma||Disease||
|
|
|
|
|
Line 2,816: Line 2,764:
|
|
|-
|-
|RPS14
|Subependymoma||Disease||
|
|
|
|
|
Line 2,826: Line 2,773:
|
|
|-
|-
|RB1
|Choroid plexus papilloma||Disease||
|
|
|
|
|
Line 2,836: Line 2,782:
|
|
|-
|-
|MPL
|Atypical choroid plexus papilloma||Disease||
|
|
|
|
|
Line 2,846: Line 2,791:
|
|
|-
|-
|CHGA
|Choroid plexus carcinoma||Disease||
|
|
|
|
|
Line 2,856: Line 2,800:
|
|
|-
|-
|CDH1
|Medulloblastoma, WNT-activated||Disease||
|
|
|
|
|
Line 2,866: Line 2,809:
|
|
|-
|-
|SRSF2
|Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
|
|
|
|
|
Line 2,876: Line 2,818:
|
|
|-
|-
|DNMT1
|Medulloblastoma, SHH-activated and TP53-mutant||Disease||
|
|
|
|
|
Line 2,886: Line 2,827:
|
|
|-
|-
|PRDX2
|Medulloblastoma, non-WNT/non-SHH||Disease||
|
|
|
|
|
Line 2,896: Line 2,836:
|
|
|-
|-
|ASXL1
|Medulloblastoma, histologically defined||Disease||
|DONE
|
|
|
|
|
|DONE
|
|
|
|
Line 2,906: Line 2,845:
|
|
|-
|-
|MN1
|Atypical teratoid/rhabdoid tumour||Disease||
|
|
|
|
|
Line 2,916: Line 2,854:
|
|
|-
|-
|SF3A1
|Cribriform neuroepithelial tumour||Disease||
|
|
|
|
Line 2,924: Line 2,862:
|
|
|
|
|-
|Embryonal tumour with multilayered rosettes||Disease||
|
|
|-
|EP300
|
|
|
|
Line 2,933: Line 2,871:
|
|
|
|
|-
|CNS neuroblastoma, FOXR2-activated||Disease||
|
|
|
|
|-
|JARID2
|
|
|
|
Line 2,942: Line 2,880:
|
|
|
|
|-
|CNS tumour with BCOR internal tandem duplication||Disease||
|
|
|
|
|
|
|-
|BRCA1
|
|
|
|
|
|
|
|
|-
|CNS embryonal tumour NEC/NOS||Disease||
|
|
|
|
|
|
|
|
|-
|BRCA2
|
|
|
|
|
|
|-
|Pineocytoma||Disease||
|
|
|
|
Line 2,965: Line 2,905:
|
|
|
|
|-
|
|
|
|
|-
|Pineal parenchymal tumour of intermediate differentiation||Disease||
|
|
|
|
Line 2,976: Line 2,917:
|
|
|-
|-
|Pineoblastoma||Disease||
|
|
|
|
|
Line 2,982: Line 2,925:
|
|
|
|
|
|-
|
|Papillary tumour of the pineal region||Disease||
|
|}
 
==WHO Central Nervous System Tumours  (5th ed.) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|- |Astrocytoma, IDH-mutant||Disease||
|
|
|
|
Line 3,006: Line 2,935:
|
|
|-
|-
|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
|
|
|
|
Line 3,015: Line 2,944:
|
|
|-
|-
|Glioblastoma, IDH-wildtype||Disease||
|Schwannoma||Disease||
|
|
|
|
Line 3,024: Line 2,953:
|
|
|-
|-
|Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
|Neurofibroma||Disease||
|
|
|
|
Line 3,033: Line 2,962:
|
|
|-
|-
|Angiocentric glioma||Disease||
|Perineurioma||Disease||
|
|
|
|
Line 3,042: Line 2,971:
|
|
|-
|-
|Polymorphous low-grade neuroepithelial tumour of the young||Disease||
|Hybrid nerve sheath tumours||Disease||
|
|
|
|
Line 3,051: Line 2,980:
|
|
|-
|-
|Diffuse low-grade glioma, MAPK pathway-altered||Disease||
|Malignant melanotic nerve sheath tumour||Disease||
|
|
|
|
Line 3,060: Line 2,989:
|
|
|-
|-
|Diffuse midline glioma, H3 K27-altered||Disease||
|Malignant peripheral nerve sheath tumour||Disease||
|
|
|
|
Line 3,069: Line 2,998:
|
|
|-
|-
|Diffuse hemispheric glioma, H3 G34-mutant||Disease||
|Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
|
|
|
|
Line 3,078: Line 3,007:
|
|
|-
|-
|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
|Meningioma||Disease||
|
|
|
|
Line 3,087: Line 3,016:
|
|
|-
|-
|Infant-type hemispheric glioma||Disease||
|Solitary fibrous tumour||Disease||
|
|
|
|
Line 3,096: Line 3,025:
|
|
|-
|-
|Pilocytic astrocytoma||Disease||
|Haemangiomas and vascular malformations||Disease||
|
|
|
|
Line 3,105: Line 3,034:
|
|
|-
|-
|High-grade astrocytoma with piloid features||Disease||
|Haemangioblastoma||Disease||
|
|
|
|
Line 3,114: Line 3,043:
|
|
|-
|-
|Pleomorphic xanthoastrocytoma||Disease||
|Rhabdomyosarcoma||Disease||
|
|
|
|
Line 3,123: Line 3,052:
|
|
|-
|-
|Subependymal giant cell astrocytoma||Disease||
|Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
|
|
|
|
Line 3,132: Line 3,061:
|
|
|-
|-
|Chordoid glioma||Disease||
|CIC-rearranged sarcoma||Disease||
|
|
|
|
Line 3,141: Line 3,070:
|
|
|-
|-
|Astroblastoma, MN1-altered||Disease||
|Primary intracranial sarcoma, DICER1-mutant||Disease||
|
|
|
|
Line 3,150: Line 3,079:
|
|
|-
|-
|Ganglioglioma||Disease||
|Ewing sarcoma||Disease||
|
|
|
|
Line 3,159: Line 3,088:
|
|
|-
|-
|Gangliocytoma||Disease||
|Mesenchymal chondrosarcoma||Disease||
|
|
|
|
Line 3,168: Line 3,097:
|
|
|-
|-
|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
|Chondrosarcoma||Disease||
|
|
|
|
Line 3,177: Line 3,106:
|
|
|-
|-
|Dysembryoplastic neuroepithelial tumour||Disease||
|Chordoma||Disease||
|
|
|
|
Line 3,186: Line 3,115:
|
|
|-
|-
|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
|
|
|
|
Line 3,195: Line 3,124:
|
|
|-
|-
|Papillary glioneuronal tumour||Disease||
|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
|
|
|
|
Line 3,204: Line 3,133:
|
|
|-
|-
|Rosette-forming glioneuronal tumour||Disease||
|Primary diffuse large B-cell lymphoma of the CNS||Disease||
|
|
|
|
Line 3,213: Line 3,142:
|
|
|-
|-
|Myxoid glioneuronal tumour||Disease||
|Immunodeficiency-associated CNS lymphomas||Disease||
|
|
|
|
Line 3,222: Line 3,151:
|
|
|-
|-
|Diffuse leptomeningeal glioneuronal tumour||Disease||
|Lymphomatoid granulomatosis||Disease||
|
|
|
|
Line 3,231: Line 3,160:
|
|
|-
|-
|Multinodular and vacuolating neuronal tumour||Disease||
|Intravascular large B-cell lymphoma||Disease||
|
|
|
|
Line 3,240: Line 3,169:
|
|
|-
|-
|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
|MALT lymphoma of the dura||Disease||
|
|
|
|
Line 3,249: Line 3,178:
|
|
|-
|-
|Central neurocytoma||Disease||
|Other low-grade B-cell lymphomas of the CNS||Disease||
|
|
|
|
Line 3,258: Line 3,187:
|
|
|-
|-
|Extraventricular neurocytoma||Disease||
|Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
|
|
|
|
Line 3,267: Line 3,196:
|
|
|-
|-
|Cerebellar liponeurocytoma||Disease||
|T-cell and NK/T-cell lymphomas||Disease||
|
|
|
|
Line 3,276: Line 3,205:
|
|
|-
|-
|Supratentorial ependymoma||Disease||
|Erdheim-Chester disease||Disease||
|
|
|
|
Line 3,285: Line 3,214:
|
|
|-
|-
|Supratentorial ependymoma, ZFTA fusion-positive||Disease||
|Rosai-Dorfman disease||Disease||
|
|
|
|
Line 3,294: Line 3,223:
|
|
|-
|-
|Supratentorial ependymoma, YAP1 fusion-positive||Disease||
|Juvenile xanthogranuloma||Disease||
|
|
|
|
Line 3,303: Line 3,232:
|
|
|-
|-
|Posterior fossa ependymoma||Disease||
|Langerhans cell histiocytosis||Disease||
|
|
|
|
Line 3,312: Line 3,241:
|
|
|-
|-
|Posterior fossa group A (PFA) ependymoma||Disease||
|Histiocytic sarcoma||Disease||
|
|
|
|
Line 3,321: Line 3,250:
|
|
|-
|-
|Posterior fossa group B (PFB) ependymoma||Disease||
|Germ cell tumours of the CNS||Disease||
|
|
|
|
Line 3,330: Line 3,259:
|
|
|-
|-
|Spinal ependymoma||Disease||
|Adamantinomatous craniopharyngioma||Disease||
|
|
|
|
Line 3,339: Line 3,268:
|
|
|-
|-
|Spinal ependymoma, MYCN-amplified||Disease||
|Papillary craniopharyngioma||Disease||
|
|
|
|
Line 3,348: Line 3,277:
|
|
|-
|-
|Myxopapillary ependymoma||Disease||
|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
|
|
|
|
Line 3,357: Line 3,286:
|
|
|-
|-
|Subependymoma||Disease||
|Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
|
|
|
|
Line 3,366: Line 3,295:
|
|
|-
|-
|Choroid plexus papilloma||Disease||
|Pituitary blastoma||Disease||
|
|
|
|
Line 3,375: Line 3,304:
|
|
|-
|-
|Atypical choroid plexus papilloma||Disease||
|Metastases to the brain and spinal cord parenchyma||Disease||
|
|
|
|
Line 3,384: Line 3,313:
|
|
|-
|-
|Choroid plexus carcinoma||Disease||
|Metastases to the meninges||Disease||
|
|
|
|
Line 3,393: Line 3,322:
|
|
|-
|-
|Medulloblastoma, WNT-activated||Disease||
|Neurofibromatosis type 1||Disease||
|
|
|
|
Line 3,402: Line 3,331:
|
|
|-
|-
|Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
|Neurofibromatosis type 2||Disease||
|
|
|
|
Line 3,411: Line 3,340:
|
|
|-
|-
|Medulloblastoma, SHH-activated and TP53-mutant||Disease||
|Schwannomatosis||Disease||
|
|
|
|
Line 3,420: Line 3,349:
|
|
|-
|-
|Medulloblastoma, non-WNT/non-SHH||Disease||
|Von Hippel-Lindau syndrome||Disease||
|
|
|
|
Line 3,429: Line 3,358:
|
|
|-
|-
|Medulloblastoma, histologically defined||Disease||
|Tuberous sclerosis||Disease||
|
|
|
|
Line 3,438: Line 3,367:
|
|
|-
|-
|Atypical teratoid/rhabdoid tumour||Disease||
|Li-Fraumeni syndrome||Disease||
|
|
|
|
Line 3,447: Line 3,376:
|
|
|-
|-
|Cribriform neuroepithelial tumour||Disease||
|Cowden syndrome||Disease||
|
|
|
|
Line 3,456: Line 3,385:
|
|
|-
|-
|Embryonal tumour with multilayered rosettes||Disease||
|Constitutional mismatch repair deficiency syndrome||Disease||
|
|
|
|
Line 3,465: Line 3,394:
|
|
|-
|-
|CNS neuroblastoma, FOXR2-activated||Disease||
|Familial adenomatous polyposis 1||Disease||
|
|
|
|
Line 3,474: Line 3,403:
|
|
|-
|-
|CNS tumour with BCOR internal tandem duplication||Disease||
|Naevoid basal cell carcinoma syndrome||Disease||
|
|
|
|
Line 3,483: Line 3,412:
|
|
|-
|-
|CNS embryonal tumour NEC/NOS||Disease||
|Rhabdoid tumour predisposition syndrome||Disease||
|
|
|
|
Line 3,492: Line 3,421:
|
|
|-
|-
|Pineocytoma||Disease||
|Carney complex||Disease||
|
|
|
|
Line 3,501: Line 3,430:
|
|
|-
|-
|Pineal parenchymal tumour of intermediate differentiation||Disease||
|DICER1 syndrome||Disease||
|
|
|
|
Line 3,510: Line 3,439:
|
|
|-
|-
|Pineoblastoma||Disease||
|Familial paraganglioma syndromes||Disease||
|
|
|
|
Line 3,519: Line 3,448:
|
|
|-
|-
|Papillary tumour of the pineal region||Disease||
|Melanoma-astrocytoma syndrome||Disease||
|
|
|
|
Line 3,528: Line 3,457:
|
|
|-
|-
|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
|Familial retinoblastoma||Disease||
|
|
|
|
Line 3,537: Line 3,466:
|
|
|-
|-
|Schwannoma||Disease||
|BAP1 tumour predisposition syndrome||Disease||
|
|
|
|
Line 3,546: Line 3,475:
|
|
|-
|-
|Neurofibroma||Disease||
|Fanconi anaemia||Disease||
|
|
|
|
Line 3,555: Line 3,484:
|
|
|-
|-
|Perineurioma||Disease||
|ELP1-medulloblastoma syndrome||Disease||
|
|
|
|
Line 3,564: Line 3,493:
|
|
|-
|-
|Hybrid nerve sheath tumours||Disease||
|}
 
==WHO Breast tumours (5th ed.) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|- |Usual ductal hyperplasia||Disease||
|
|
|
|
Line 3,573: Line 3,514:
|
|
|-
|-
|Malignant melanotic nerve sheath tumour||Disease||
|Columnar cell lesions, including flat epithelial atypia||Disease||
|
|
|
|
Line 3,582: Line 3,523:
|
|
|-
|-
|Malignant peripheral nerve sheath tumour||Disease||
|Atypical ductal hyperplasia||Disease||
|
|
|
|
Line 3,591: Line 3,532:
|
|
|-
|-
|Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
|Sclerosing adenosis||Disease||
|
|
|
|
Line 3,600: Line 3,541:
|
|
|-
|-
|Meningioma||Disease||
|Apocrine adenosis and adenoma||Disease||
|
|
|
|
Line 3,609: Line 3,550:
|
|
|-
|-
|Solitary fibrous tumour||Disease||
|Microglandular adenosis||Disease||
|
|
|
|
Line 3,618: Line 3,559:
|
|
|-
|-
|Haemangiomas and vascular malformations||Disease||
|Radial scar / complex sclerosing lesion||Disease||
|
|
|
|
Line 3,627: Line 3,568:
|
|
|-
|-
|Haemangioblastoma||Disease||
|Tubular adenoma||Disease||
|
|
|
|
Line 3,636: Line 3,577:
|
|
|-
|-
|Rhabdomyosarcoma||Disease||
|Lactating adenoma||Disease||
|
|
|
|
Line 3,645: Line 3,586:
|
|
|-
|-
|Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
|Ductal adenoma||Disease||
|
|
|
|
Line 3,654: Line 3,595:
|
|
|-
|-
|CIC-rearranged sarcoma||Disease||
|Pleomorphic adenoma||Disease||
|
|
|
|
Line 3,663: Line 3,604:
|
|
|-
|-
|Primary intracranial sarcoma, DICER1-mutant||Disease||
|Adenomyoepithelioma||Disease||
|
|
|
|
Line 3,672: Line 3,613:
|
|
|-
|-
|Ewing sarcoma||Disease||
|Malignant adenomyoepithelioma||Disease||
|
|
|
|
Line 3,681: Line 3,622:
|
|
|-
|-
|Mesenchymal chondrosarcoma||Disease||
|Intraductal papilloma||Disease||
|
|
|
|
Line 3,690: Line 3,631:
|
|
|-
|-
|Chondrosarcoma||Disease||
|Papillary ductal carcinoma in situ||Disease||
|
|
|
|
Line 3,699: Line 3,640:
|
|
|-
|-
|Chordoma||Disease||
|Encapsulated papillary carcinoma||Disease||
|
|
|
|
Line 3,708: Line 3,649:
|
|
|-
|-
|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
|Solid papillary carcinoma (in situ and invasive)||Disease||
|
|
|
|
Line 3,717: Line 3,658:
|
|
|-
|-
|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
|Invasive papillary carcinoma||Disease||
|
|
|
|
Line 3,726: Line 3,667:
|
|
|-
|-
|Primary diffuse large B-cell lymphoma of the CNS||Disease||
|Atypical lobular hyperplasia||Disease||
|
|
|
|
Line 3,735: Line 3,676:
|
|
|-
|-
|Immunodeficiency-associated CNS lymphomas||Disease||
|Lobular carcinoma in situ||Disease||
|
|
|
|
Line 3,744: Line 3,685:
|
|
|-
|-
|Lymphomatoid granulomatosis||Disease||
|Ductal carcinoma in situ||Disease||
|
|
|
|
Line 3,753: Line 3,694:
|
|
|-
|-
|Intravascular large B-cell lymphoma||Disease||
|Invasive breast carcinoma: General overview||Disease||
|
|
|
|
Line 3,762: Line 3,703:
|
|
|-
|-
|MALT lymphoma of the dura||Disease||
|Invasive breast carcinoma of no special type||Disease||
|
|
|
|
Line 3,771: Line 3,712:
|
|
|-
|-
|Other low-grade B-cell lymphomas of the CNS||Disease||
|Microinvasive carcinoma||Disease||
|
|
|
|
Line 3,780: Line 3,721:
|
|
|-
|-
|Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
|Invasive lobular carcinoma||Disease||
|
|
|
|
Line 3,789: Line 3,730:
|
|
|-
|-
|T-cell and NK/T-cell lymphomas||Disease||
|Tubular carcinoma||Disease||
|
|
|
|
Line 3,798: Line 3,739:
|
|
|-
|-
|Erdheim-Chester disease||Disease||
|Cribriform carcinoma||Disease||
|
|
|
|
Line 3,807: Line 3,748:
|
|
|-
|-
|Rosai-Dorfman disease||Disease||
|Mucinous carcinoma||Disease||
|
|
|
|
Line 3,816: Line 3,757:
|
|
|-
|-
|Juvenile xanthogranuloma||Disease||
|Mucinous cystadenocarcinoma||Disease||
|
|
|
|
Line 3,825: Line 3,766:
|
|
|-
|-
|Langerhans cell histiocytosis||Disease||
|Invasive micropapillary carcinoma||Disease||
|
|
|
|
Line 3,834: Line 3,775:
|
|
|-
|-
|Histiocytic sarcoma||Disease||
|Carcinoma with apocrine differentiation||Disease||
|
|
|
|
Line 3,843: Line 3,784:
|
|
|-
|-
|Germ cell tumours of the CNS||Disease||
|Metaplastic carcinoma||Disease||
|
|
|
|
Line 3,852: Line 3,793:
|
|
|-
|-
|Adamantinomatous craniopharyngioma||Disease||
|Acinic cell carcinoma||Disease||
|
|
|
|
Line 3,861: Line 3,802:
|
|
|-
|-
|Papillary craniopharyngioma||Disease||
|Adenoid cystic carcinoma||Disease||
|
|
|
|
Line 3,870: Line 3,811:
|
|
|-
|-
|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
|Secretory carcinoma||Disease||
|
|
|
|
Line 3,879: Line 3,820:
|
|
|-
|-
|Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
|Mucoepidermoid carcinoma||Disease||
|
|
|
|
Line 3,888: Line 3,829:
|
|
|-
|-
|Pituitary blastoma||Disease||
|Polymorphous adenocarcinoma||Disease||
|
|
|
|
Line 3,897: Line 3,838:
|
|
|-
|-
|Metastases to the brain and spinal cord parenchyma||Disease||
|Tall cell carcinoma with reversed polarity||Disease||
|
|
|
|
Line 3,906: Line 3,847:
|
|
|-
|-
|Metastases to the meninges||Disease||
|Neuroendocrine tumour||Disease||
|
|
|
|
Line 3,915: Line 3,856:
|
|
|-
|-
|Neurofibromatosis type 1||Disease||
|Neuroendocrine carcinoma||Disease||
|
|
|
|
Line 3,924: Line 3,865:
|
|
|-
|-
|Neurofibromatosis type 2||Disease||
|Hamartoma||Disease||
|
|
|
|
Line 3,933: Line 3,874:
|
|
|-
|-
|Schwannomatosis||Disease||
|Fibroadenoma||Disease||
|
|
|
|
Line 3,942: Line 3,883:
|
|
|-
|-
|Von Hippel-Lindau syndrome||Disease||
|Phyllodes tumour||Disease||
|
|
|
|
Line 3,951: Line 3,892:
|
|
|-
|-
|Tuberous sclerosis||Disease||
|Syringomatous tumour||Disease||
|
|
|
|
Line 3,960: Line 3,901:
|
|
|-
|-
|Li-Fraumeni syndrome||Disease||
|Nipple adenoma||Disease||
|
|
|
|
Line 3,969: Line 3,910:
|
|
|-
|-
|Cowden syndrome||Disease||
|Paget disease of the breast||Disease||
|
|
|
|
Line 3,978: Line 3,919:
|
|
|-
|-
|Constitutional mismatch repair deficiency syndrome||Disease||
|Haemangioma||Disease||
|
|
|
|
Line 3,987: Line 3,928:
|
|
|-
|-
|Familial adenomatous polyposis 1||Disease||
|Angiomatosis||Disease||
|
|
|
|
Line 3,996: Line 3,937:
|
|
|-
|-
|Naevoid basal cell carcinoma syndrome||Disease||
|Atypical vascular lesions||Disease||
|
|
|
|
Line 4,005: Line 3,946:
|
|
|-
|-
|Rhabdoid tumour predisposition syndrome||Disease||
|Postradiation angiosarcoma of the breast||Disease||
|
|
|
|
Line 4,014: Line 3,955:
|
|
|-
|-
|Carney complex||Disease||
|Primary angiosarcoma of the breast||Disease||
|
|
|
|
Line 4,023: Line 3,964:
|
|
|-
|-
|DICER1 syndrome||Disease||
|Nodular fasciitis||Disease||
|
|
|
|
Line 4,032: Line 3,973:
|
|
|-
|-
|Familial paraganglioma syndromes||Disease||
|Myofibroblastoma||Disease||
|
|
|
|
Line 4,041: Line 3,982:
|
|
|-
|-
|Melanoma-astrocytoma syndrome||Disease||
|Desmoid fibromatosis||Disease||
|
|
|
|
Line 4,050: Line 3,991:
|
|
|-
|-
|Familial retinoblastoma||Disease||
|Inflammatory myofibroblastic tumour||Disease||
|
|
|
|
Line 4,059: Line 4,000:
|
|
|-
|-
|BAP1 tumour predisposition syndrome||Disease||
|Schwannoma||Disease||
|
|
|
|
Line 4,068: Line 4,009:
|
|
|-
|-
|Fanconi anaemia||Disease||
|Neurofibroma||Disease||
|
|
|
|
Line 4,077: Line 4,018:
|
|
|-
|-
|ELP1-medulloblastoma syndrome||Disease||
|Granular cell tumour||Disease||
|
|
|
|
Line 4,086: Line 4,027:
|
|
|-
|-
|}
|Leiomyoma||Disease||
 
==WHO Breast tumours  (5th ed.) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|- |Usual ductal hyperplasia||Disease||
|
|
|
|
Line 4,107: Line 4,036:
|
|
|-
|-
|Columnar cell lesions, including flat epithelial atypia||Disease||
|Leiomyosarcoma||Disease||
|
|
|
|
Line 4,116: Line 4,045:
|
|
|-
|-
|Atypical ductal hyperplasia||Disease||
|Lipoma||Disease||
|
|
|
|
Line 4,125: Line 4,054:
|
|
|-
|-
|Sclerosing adenosis||Disease||
|Angiolipoma||Disease||
|
|
|
|
Line 4,134: Line 4,063:
|
|
|-
|-
|Apocrine adenosis and adenoma||Disease||
|Liposarcoma||Disease||
|
|
|
|
Line 4,143: Line 4,072:
|
|
|-
|-
|Microglandular adenosis||Disease||
|Pseudoangiomatous stromal hyperplasia||Disease||
|
|
|
|
Line 4,152: Line 4,081:
|
|
|-
|-
|Radial scar / complex sclerosing lesion||Disease||
|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)||Disease||
|
|
|
|
Line 4,161: Line 4,090:
|
|
|-
|-
|Tubular adenoma||Disease||
|Follicular lymphoma||Disease||
|
|
|
|
Line 4,170: Line 4,099:
|
|
|-
|-
|Lactating adenoma||Disease||
|Diffuse large B-cell lymphoma||Disease||
|
|
|
|
Line 4,179: Line 4,108:
|
|
|-
|-
|Ductal adenoma||Disease||
|Burkitt lymphoma||Disease||
|
|
|
|
Line 4,188: Line 4,117:
|
|
|-
|-
|Pleomorphic adenoma||Disease||
|Breast implant-associated anaplastic large cell lymphoma||Disease||
|
|
|
|
Line 4,197: Line 4,126:
|
|
|-
|-
|Adenomyoepithelioma||Disease||
|Gynaecomastia||Disease||
|
|
|
|
Line 4,206: Line 4,135:
|
|
|-
|-
|Malignant adenomyoepithelioma||Disease||
|Carcinoma in situ||Disease||
|
|
|
|
Line 4,215: Line 4,144:
|
|
|-
|-
|Intraductal papilloma||Disease||
|Invasive carcinoma||Disease||
|
|
|
|
Line 4,224: Line 4,153:
|
|
|-
|-
|Papillary ductal carcinoma in situ||Disease||
|Metastases to the breast||Disease||
|
|
|
|
Line 4,233: Line 4,162:
|
|
|-
|-
|Encapsulated papillary carcinoma||Disease||
|BRCA1/2-associated hereditary breast and ovarian cancer syndrome||Disease||
|
|
|
|
Line 4,242: Line 4,171:
|
|
|-
|-
|Solid papillary carcinoma (in situ and invasive)||Disease||
|Cowden syndrome||Disease||
|
|
|
|
Line 4,251: Line 4,180:
|
|
|-
|-
|Invasive papillary carcinoma||Disease||
|Ataxia-telangiectasia||Disease||
|
|
|
|
Line 4,260: Line 4,189:
|
|
|-
|-
|Atypical lobular hyperplasia||Disease||
|Li-Fraumeni syndrome, TP53-associated||Disease||
|
|
|
|
Line 4,269: Line 4,198:
|
|
|-
|-
|Lobular carcinoma in situ||Disease||
|Li-Fraumeni syndrome, CHEK2-associated||Disease||
|
|
|
|
Line 4,278: Line 4,207:
|
|
|-
|-
|Ductal carcinoma in situ||Disease||
|CDH1-associated breast cancer||Disease||
|
|
|
|
Line 4,287: Line 4,216:
|
|
|-
|-
|Invasive breast carcinoma: General overview||Disease||
|PALB2-associated cancers||Disease||
|
|
|
|
Line 4,296: Line 4,225:
|
|
|-
|-
|Invasive breast carcinoma of no special type||Disease||
|Peutz-Jeghers syndrome||Disease||
|
|
|
|
Line 4,305: Line 4,234:
|
|
|-
|-
|Microinvasive carcinoma||Disease||
|Neurofibromatosis type 1||Disease||
|
|
|
|
Line 4,314: Line 4,243:
|
|
|-
|-
|Invasive lobular carcinoma||Disease||
|}
|
 
|
==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
{| class="wikitable sortable"
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|BCR
|Brian Davis
|
|
|
|
|Complete
|8/10/18
|
|
|
|
|
|
|-
|-
|Tubular carcinoma||Disease||
|ABL1
|
|Brian Davis
|
|
|
|
|
|Complete
|4/16/19
|
|
|
|
|
|
|-
|-
|Cribriform carcinoma||Disease||
|RUNX1
|Brian Davis
|
|
|
|
|Complete
|6/9/19
|
|
|
|
|
|
|-
|RUNX1T1
|Brian Davis
|
|
|
|
|-
|Complete
|Mucinous carcinoma||Disease||
|5/23/19
|
|
|
|
|
|
|-
|MYH11
|Brian Davis
|
|
|
|Complete
|8/6/18
|
|
|
|
|
|
|-
|-
|Mucinous cystadenocarcinoma||Disease||
|FLT3
|
|Kay Weng Choy
|
|
|
|
|Complete
|
|
|
|
Line 4,359: Line 4,317:
|
|
|-
|-
|Invasive micropapillary carcinoma||Disease||
|NPM1
|
|Kay Weng Choy
|
|
|
|
|Complete
|
|
|
|
Line 4,368: Line 4,327:
|
|
|-
|-
|Carcinoma with apocrine differentiation||Disease||
|TP53
|
|Kay Weng Choy
|
|
|
|
|Complete
|
|
|
|
Line 4,377: Line 4,337:
|
|
|-
|-
|Metaplastic carcinoma||Disease||
|DNMT3A
|
|Kay Weng Choy
|
|
|
|
|Complete
|
|
|
|
Line 4,386: Line 4,347:
|
|
|-
|-
|Acinic cell carcinoma||Disease||
|CEBPA
|
|Gordana
|
|
|
|
|Complete
|
|
|
|
Line 4,395: Line 4,357:
|
|
|-
|-
|Adenoid cystic carcinoma||Disease||
|IDH1
|
|Paul De Fazio
|
|
|
|
|Complete
|
|
|
|
Line 4,404: Line 4,367:
|
|
|-
|-
|Secretory carcinoma||Disease||
|IDH2
|
|Paul De Fazio
|
|
|
|
|Complete
|
|
|
|
Line 4,413: Line 4,377:
|
|
|-
|-
|Mucoepidermoid carcinoma||Disease||
|PML
|
|Brian Davis
|
|
|
|
|
|Complete
|12/5/18
|
|
|
|
|
|
|-
|-
|Polymorphous adenocarcinoma||Disease||
|RARA
|
|Brian Davis
|
|
|
|
|
|Complete
|8/3/18
|
|
|
|
|
|
|-
|-
|Tall cell carcinoma with reversed polarity||Disease||
|ETV6
|
|Brian Davis
|
|
|
|
|
|Complete
|6/9/19
|
|
|
|
|
|
|-
|-
|Neuroendocrine tumour||Disease||
|KIT
|
|Brian Davis
|
|
|
|
|
|Complete
|10/1/18
|
|
|
|
|
|
|-
|-
|Neuroendocrine carcinoma||Disease||
|CBFB
|
|Brian Davis
|
|
|
|
|
|Complete
|8/2/18
|
|
|
|
|
|
|-
|-
|Hamartoma||Disease||
|GATA2
|
|Kay Weng Choy
|
|
|
|
|Complete
|
|
|
|
Line 4,467: Line 4,437:
|
|
|-
|-
|Fibroadenoma||Disease||
|PTEN
|Beth Pitel
|
|
|
|
|Pending
|
|
|
|
|
|
|
|
|-
|MLTT3
|
|
|-
|Phyllodes tumour||Disease||
|
|
|
|
Line 4,485: Line 4,457:
|
|
|-
|-
|Syringomatous tumour||Disease||
|MECOM
|
|Brian Davis
|
|
|
|
|Pending
|
|
|
|
Line 4,494: Line 4,467:
|
|
|-
|-
|Nipple adenoma||Disease||
|FGFR1(FLT2)
|Brian Davis
|
|
|
|
|Pending
|
|
|
|
|
|
|
|
|-
|KMT2A
|
|
|-
|Paget disease of the breast||Disease||
|
|
|
|
Line 4,512: Line 4,487:
|
|
|-
|-
|Haemangioma||Disease||
|DEK
|
|Wahab A. Khan
|
|
|
|
|Pending
|
|
|
|
Line 4,521: Line 4,497:
|
|
|-
|-
|Angiomatosis||Disease||
|NUP214
|Wahab A. Khan
|
|
|
|
|Pending
|
|
|
|
|
|
|
|
|-
|RBM15
|
|
|-
|Atypical vascular lesions||Disease||
|
|
|
|
Line 4,539: Line 4,517:
|
|
|-
|-
|Postradiation angiosarcoma of the breast||Disease||
|MKL1
|
|
|
|
|
Line 4,548: Line 4,527:
|
|
|-
|-
|Primary angiosarcoma of the breast||Disease||
|DDX41
|
|Ying Zou
|8/7/20
|
|
|Pending
|
|
|
|
|
|
|
|
|-
|ANKRD26
|
|
|-
|Nodular fasciitis||Disease||
|
|
|
|
Line 4,566: Line 4,547:
|
|
|-
|-
|Myofibroblastoma||Disease||
|CUX1
|
|
|
|
|
Line 4,575: Line 4,557:
|
|
|-
|-
|Desmoid fibromatosis||Disease||
|TET2
|
|
|
|
|
Line 4,584: Line 4,567:
|
|
|-
|-
|Inflammatory myofibroblastic tumour||Disease||
|EZH2
|
|
|
|
|
Line 4,593: Line 4,577:
|
|
|-
|-
|Schwannoma||Disease||
|FOXP1
|
|
|
|
|
Line 4,602: Line 4,587:
|
|
|-
|-
|Neurofibroma||Disease||
|MYC
|
|
|
|
|
Line 4,611: Line 4,597:
|
|
|-
|-
|Granular cell tumour||Disease||
|JAK2
|
|
|
|
|
Line 4,620: Line 4,607:
|
|
|-
|-
|Leiomyoma||Disease||
|WT1
|DONE
|
|
|
|
|DONE
|
|
|
|
|
|
|
|
|-
|CBL
|
|
|-
|Leiomyosarcoma||Disease||
|
|
|
|
Line 4,638: Line 4,627:
|
|
|-
|-
|Lipoma||Disease||
|NF1
|
|
|
|
|
Line 4,647: Line 4,637:
|
|
|-
|-
|Angiolipoma||Disease||
|SUZ12
|
|
|
|
|
Line 4,656: Line 4,647:
|
|
|-
|-
|Liposarcoma||Disease||
|ERG
|
|
|
|
|
Line 4,665: Line 4,657:
|
|
|-
|-
|Pseudoangiomatous stromal hyperplasia||Disease||
|EST2
|
|
|
|
|
Line 4,674: Line 4,667:
|
|
|-
|-
|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)||Disease||
|RPS14
|
|
|
|
|
Line 4,683: Line 4,677:
|
|
|-
|-
|Follicular lymphoma||Disease||
|RB1
|
|
|
|
|
Line 4,692: Line 4,687:
|
|
|-
|-
|Diffuse large B-cell lymphoma||Disease||
|MPL
|
|
|
|
|
Line 4,701: Line 4,697:
|
|
|-
|-
|Burkitt lymphoma||Disease||
|CHGA
|
|
|
|
|
Line 4,710: Line 4,707:
|
|
|-
|-
|Breast implant-associated anaplastic large cell lymphoma||Disease||
|CDH1
|
|
|
|
|
Line 4,719: Line 4,717:
|
|
|-
|-
|Gynaecomastia||Disease||
|SRSF2
|
|
|
|
|
Line 4,728: Line 4,727:
|
|
|-
|-
|Carcinoma in situ||Disease||
|DNMT1
|
|
|
|
|
Line 4,737: Line 4,737:
|
|
|-
|-
|Invasive carcinoma||Disease||
|PRDX2
|
|
|
|
|
Line 4,746: Line 4,747:
|
|
|-
|-
|Metastases to the breast||Disease||
|ASXL1
|DONE
|
|
|
|
|DONE
|
|
|
|
|
|
|
|
|-
|MN1
|
|
|-
|BRCA1/2-associated hereditary breast and ovarian cancer syndrome||Disease||
|
|
|
|
Line 4,764: Line 4,767:
|
|
|-
|-
|Cowden syndrome||Disease||
|SF3A1
|
|
|
|
|
Line 4,773: Line 4,777:
|
|
|-
|-
|Ataxia-telangiectasia||Disease||
|EP300
|
|
|
|
|
Line 4,782: Line 4,787:
|
|
|-
|-
|Li-Fraumeni syndrome, TP53-associated||Disease||
|JARID2
|
|
|
|
|
Line 4,791: Line 4,797:
|
|
|-
|-
|Li-Fraumeni syndrome, CHEK2-associated||Disease||
|BRCA1
|
|
|
|
|
Line 4,800: Line 4,807:
|
|
|-
|-
|CDH1-associated breast cancer||Disease||
|BRCA2
|
|
|
|
|
Line 4,809: Line 4,817:
|
|
|-
|-
|PALB2-associated cancers||Disease||
|
|
|
|
|
|
|
|
|
|
|
|-
|Peutz-Jeghers syndrome||Disease||
|
|
|
|
Line 4,824: Line 4,826:
|
|
|
|
|-
|
|
|
|
|-
|Neurofibromatosis type 1||Disease||
|
|
|
|
Line 4,835: Line 4,836:
|
|
|
|
|-
|}
|}


​
​
Retrieved from "https://test.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"